Submitted by: Submitted by Marketreport
Views: 10
Words: 533
Pages: 3
Category: Business and Industry
Date Submitted: 10/13/2016 11:48 PM
According to Stratistics MRC, the Global Biosimilars market is estimated to be $3.5 billion in 2015 with a CAGR of 23.8% is poised to reach $15.6 billion by 2022. High end adoption of off patented drugs has experienced robust market growth. Some of the factors which are triggering the market growth include growing incidences of diseases, rising demand for biosimilars drugs owing to their cost effectiveness and increasing demand to limit healthcare expenditures. However, stringent government regulations will affect biosimilars investments.
Chronic & Autoimmune disorders segment is expected to grow at a highest CAGR during the forecast period owing to increasing incidences of autoimmune disorders. By geography, Europe dominated the global biosimilars market due to growing appearance of new market participants in this region. However, Asia Pacific is anticipated to grow at a highest CAGR during the forecast period due to rising funds towards the expansion of biosimilars market.
Browse full report with TOC@ https://marketreportscenter.com/reports/415439/biosimilar-global-market-outlook-2016-2022
Some of the key players in this market include are Mylan, Inc., Dr. Reddy's Laboratories, Amgen Inc., Sandoz International GmbH , Hospira, Inc., Merck KGAA, Celltrion, Inc., Biocon Ltd. , Teva Pharmaceutical Industries Ltd. and Roche Diagnostics.
Products Covered:
Peptides
Erythropoietin
Interferon
Human Growth Hormone
Monoclonal Antibodies
Granulocyte Colony Stimulating Factor (G-CSF)
Insulin
Other Products
Technology Covered:
Bioassay
Mass Spectrometry
Nuclear magnetic resonance (NMR) technology
Recombinant DNA Technology (rDNA technology)
Western Blotting
Electrophoresis
Chromatography
Monoclonal Antibodies (MAb) Technology
Application Covered:
Growth Hormone Deficiency
Chronic and Autoimmune Diseases
Blood Disorders
Oncology Diseases
Other Applications
Service Covered:
Clinical Trials
Contract Research and Manufacturing Services...